Skip to content

Could a daily pill stop a person from getting HIV?

Rarely an emergency: cohort data on short-term AIDS risk may inform decision to start

Scaling up antiretroviral therapy: learning from Thailand

Tenofovir: no price reduction offer for resource-limited countries yet

Evidence unclear as to whether gay men are having more risky sex

Limited efficacy of preventive therapy among HIV-infected miners

Scaling up antiretroviral therapy: learning from Botswana

Liver function tests predict risk of death in HIV patients

Yale Med School reports rising hospitalisation rates and increasing cost of HIV care